Jun 11, 2020
Verge Genomics to advance its inhibitors of PIKfyve for the treatment of ALS and COVID-19
Jun 04, 2020
AlzeCure Announces Positive Data From Clinical Study with ACD856
Jun 04, 2020
IRLAB's Phase IIb/III Study in Parkinson's disease to Target Good ON
Jun 02, 2020
Surgical Information Sciences Announces CE Mark for its DBS Visualization Guiding System
May 28, 2020
The Michael J. Fox Foundation Collaborates with ESPN Founder Bill Rasmussen to Champion Engagement of Newly Diagnosed Parkinson's Patients in Research
May 26, 2020
Impact of Baseline Dyskinesia on Safety and Efficacy of NOURIANZ® (istradefylline) in Patients with Parkinson's Disease Presented During "Virtual" European Academy of Neurology Meeting
May 22, 2020
Second Parkinson's Therapy Funded by The Michael J. Fox Foundation Receives FDA Approval and Advances to Market
May 21, 2020
HKBU invents nanostructure that stimulates growth of stem cells for Parkinson's disease treatment
May 14, 2020
Erisyon Awarded Michael J. Fox Foundation Grant to Validate Methods for Early Parkinson's Detection
May 13, 2020
Neurocrine Biosciences to Present Data from its Movement Disorder Portfolio on the American Academy of Neurology Science Highlights Platform
May 13, 2020
Analysis of Parkinson's Disease Markets, Worldwide, 2016-2024
May 07, 2020
The American Parkinson Disease Association (APDA) Kicks-Off 2020 National Optimism Walk Series
May 04, 2020
Navigating COVID-19 When You Have Parkinson's Disease
Apr 29, 2020
The Michael J. Fox Foundation Releases New Video Resource to Empower Patients and Families to Participate in Critical Parkinson's Research
Apr 27, 2020
Neurocrine Biosciences Announces FDA Approval of Once-Daily ONGENTYS® (opicapone) as an Add-On Treatment for Patients with Parkinson's Disease Experiencing "Off" Episodes
Apr 15, 2020
Parkinson Voice Project Saves Voices During COVID-19
Apr 15, 2020
ICBII Announces the Approval of its latest patent on Blood-Brain Barrier Permeable Technology accelerating the company's progress towards treating Neuro-Degenerative Alzheimer's and Parkinson's Diseases.
Apr 01, 2020
Aspen Neuroscience Announces $70 Million Series A Financing Led by OrbiMed to Advance Development of the First Autologous Neuron Replacement Therapy to Treat Parkinson Disease
Mar 31, 2020
Deep Brain Stimulation Devices Market Size Worth $2.16 Billion by 2027: Grand View Research, Inc.
Mar 26, 2020
Brian Grant Foundation Launches Grant's Army Online Education Program for Parkinson's Exercise Professionals